Replay available

Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call

Beta Bionics, Inc. (NASDAQ: BBNX) Q2 2025 earnings conference call, held 2025-07-29. Replay captured from the company's public earnings webcast.

Tue, July 29, 2025 at 4:30 PMendedReplay
Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Blake Beaver

Head of Investor Relations

Sean Saint

Chief Executive Officer

Steven Feider

Chief Financial Officer

Stephanie Piazzolla

Analyst, Bank of America

Richard Newwater

Analyst, Truist

Frank Tatikian

Analyst, Lake Street

Jeff Johnson

Analyst, Beard Research

Jeffrey Cohen

Analyst, Ladenburg Thalmann

Replay transcript excerpt

Good afternoon, and welcome to the Beta Bionics second quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session, and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded. I would now like to turn the conference over to Blake Beaver, head of investor relations. Please go ahead. Thank you. Good afternoon and thank you for tuning in to Beta Bionic's second quarter 2025 earnings call. Joining me for today's call are Chief Executive Officer Sean Saint and Chief Financial Officer Steven Feider. Both the replay of this call and the press release discussing our second quarter 2025 results will be available on the investor relations section of our website. The replay will be available for approximately one year following the conclusion of this call. Information recorded on this call speaks only as of today, July 29, 2025. Therefore, if you are listening to the replay, any time sensitive information may no longer be accurate. Also on our website is our supplemental second quarter 2025 earnings presentation and updated corporate presentation. We encourage you to refer to those documents for a summary of key metrics and business updates. Before we begin, we'd like to remind you that today's discussion will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance, and operating plans. Please refer to the cautionary statements in the press release we issued earlier today, as well as our SEC filings, including our Form...

More from Beta Bionics, Inc.